Past version: Effective from 18 Jul 2025 to 30 Jun 2007 To view other versions open the versions tab on the right
An investment firm licensee must not redeem any Tier 1 instrument that it has included in its Regulatory Capital for the purpose of satisfying its Regulatory Capital Requirement without the prior written approval of the BMA.